John L Bass

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device
    John L Bass
    University of Minnesota, Amplatz Children s Hospital, Minneapolis, Minnesota 55455, USA
    Catheter Cardiovasc Interv 79:1153-60. 2012
  2. ncbi Initial human experience with the Amplatzer perimembranous ventricular septal occluder device
    John L Bass
    Department of Pediatric Cardiology, University of Minnesota, Minneapolis, Minnesota, USA
    Catheter Cardiovasc Interv 58:238-45. 2003
  3. ncbi Transcatheter occlusion of the left atrial appendage--experimental testing of a new Amplatzer device
    John L Bass
    Department of Pediatrics Division Pediatric Cardiology, University of Minnesota Amplatz Children s Hospital, Minneapolis, MN 55455, USA
    Catheter Cardiovasc Interv 76:181-5. 2010
  4. ncbi Experimental evaluation of a new articulated Amplatzer ductal occluder device without fabric
    Daniel H Gruenstein
    University of Minnesota Children s Hospital, Fairview, Pediatric Cardiology, MMC 94, 420 Delaware St SE, Minneapolis, Minnesota 55455, USA
    Catheter Cardiovasc Interv 74:482-7. 2009
  5. ncbi Usefulness of bone marrow transplantation in the Hurler syndrome
    Elizabeth A Braunlin
    University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA
    Am J Cardiol 92:882-6. 2003
  6. ncbi Echocardiographic assessment of ductal anatomy in premature infants-lessons for device design
    Matthew Trefz
    Pediatric Cardiology, Amplatz Children s Hospital, University of Minnesota, 410 Delaware Street NE, MMC 94, Minneapolis, MN 55455, USA
    Echocardiography 27:575-9. 2010
  7. ncbi Permanent pacemaker for atrioventricular conduction block after operative repair of perimembranous ventricular septal defect
    Elliot M Tucker
    Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Am Coll Cardiol 50:1196-200. 2007
  8. ncbi Pericardial effusion after pediatric hematopoietic cell transplant
    Osamah Aldoss
    Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Amplatz Children s Hospital, Minneapolis, MN, USA
    Pediatr Transplant 17:294-9. 2013
  9. ncbi Transesophageal echocardiography guidance for repair of complex cardiac injuries
    Shaun P Setty
    Division of Thoracic and Cardiovascular Surgery, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Ann Thorac Surg 82:2289-92. 2006
  10. ncbi Corrosive behaviour of Amplatzer devices in experimental and biological environments
    Huafu Kong
    Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA
    Cardiol Young 12:260-5. 2002

Collaborators

Detail Information

Publications15

  1. ncbi Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device
    John L Bass
    University of Minnesota, Amplatz Children s Hospital, Minneapolis, Minnesota 55455, USA
    Catheter Cardiovasc Interv 79:1153-60. 2012
    ..This study assessed the feasibility and efficacy of implanting a new nitinol device for closure of perimembranous ventricular septal defects in a swine model...
  2. ncbi Initial human experience with the Amplatzer perimembranous ventricular septal occluder device
    John L Bass
    Department of Pediatric Cardiology, University of Minnesota, Minneapolis, Minnesota, USA
    Catheter Cardiovasc Interv 58:238-45. 2003
    ..In the 25 subjects with the device left in place, device-related aortic or tricuspid insufficiency, arrhythmias, and embolization were not observed. These excellent acute results need to be confirmed by long-term follow-up...
  3. ncbi Transcatheter occlusion of the left atrial appendage--experimental testing of a new Amplatzer device
    John L Bass
    Department of Pediatrics Division Pediatric Cardiology, University of Minnesota Amplatz Children s Hospital, Minneapolis, MN 55455, USA
    Catheter Cardiovasc Interv 76:181-5. 2010
    ..This study assessed the feasibility and efficacy of implanting a new nitinol device in the left atrial appendage (LAA) in a canine model...
  4. ncbi Experimental evaluation of a new articulated Amplatzer ductal occluder device without fabric
    Daniel H Gruenstein
    University of Minnesota Children s Hospital, Fairview, Pediatric Cardiology, MMC 94, 420 Delaware St SE, Minneapolis, Minnesota 55455, USA
    Catheter Cardiovasc Interv 74:482-7. 2009
    ..To describe a new percutaneous PDA device...
  5. ncbi Usefulness of bone marrow transplantation in the Hurler syndrome
    Elizabeth A Braunlin
    University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA
    Am J Cardiol 92:882-6. 2003
    ..Cardiac ultrasound findings of patients with this syndrome >10 years after successful bone marrow transplantation are described...
  6. ncbi Echocardiographic assessment of ductal anatomy in premature infants-lessons for device design
    Matthew Trefz
    Pediatric Cardiology, Amplatz Children s Hospital, University of Minnesota, 410 Delaware Street NE, MMC 94, Minneapolis, MN 55455, USA
    Echocardiography 27:575-9. 2010
    ..A discussion for percutaneous ductal occlusion in preterm infants...
  7. ncbi Permanent pacemaker for atrioventricular conduction block after operative repair of perimembranous ventricular septal defect
    Elliot M Tucker
    Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Am Coll Cardiol 50:1196-200. 2007
    ....
  8. ncbi Pericardial effusion after pediatric hematopoietic cell transplant
    Osamah Aldoss
    Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Amplatz Children s Hospital, Minneapolis, MN, USA
    Pediatr Transplant 17:294-9. 2013
    ..In summary, PE is a common and significant complication of pediatric allo-HCT. Prospective studies are needed to better determine the etiology and optimal method of PE treatment after HCT...
  9. ncbi Transesophageal echocardiography guidance for repair of complex cardiac injuries
    Shaun P Setty
    Division of Thoracic and Cardiovascular Surgery, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Ann Thorac Surg 82:2289-92. 2006
    ..We used transesophageal echocardiography to characterize these multiple defects to help guide successful surgical repair. The patient recovered uneventfully...
  10. ncbi Corrosive behaviour of Amplatzer devices in experimental and biological environments
    Huafu Kong
    Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA
    Cardiol Young 12:260-5. 2002
    ..There is no increase of concentrations of nickel in the blood of patients who have received Amplatzer nitinol devices. These favorable testing results reveal that nickel-titanium is an inert, corrosion resistant alloy...
  11. ncbi PFO closure complications from the AGA registry
    Zahid Amin
    Rush University Medical Center, Chicago, Illinois 60612, USA
    Catheter Cardiovasc Interv 72:74-9. 2008
    ....
  12. ncbi Percutaneous closure of a large PDA in a 35-year-old man with elevated pulmonary vascular resistance
    John S Hokanson
    Pediatric Cardiology, University of Wisconsin, Madison, WI 53792, USA
    Congenit Heart Dis 3:149-54. 2008
    ..The use of prior balloon test occlusion of the PDA suggested that the procedure would be successful, despite the lack of an immediate fall in the pulmonary artery pressure...
  13. ncbi Initial experience with the Amplatzer membranous septal occluder in adults
    Rafael Hirsch
    Adult Congenital Heart Disease Unit and Departments of Cardiology, Rabin Medical Center, Petach Tikva 49100, Israel
    Acute Card Care 9:54-9. 2007
    ..A trans-catheter technique for closing pmVSDs has been developed, and this paper describes our initial experience using the Amplatzer membranous septal occluder (AMSO)...
  14. ncbi Transcatheter closure of large secundum atrial septal defects using the 40 mm Amplatzer septal occluder: results of an international registry
    Keila Lopez
    University of Chicago Comer Children's Hospital, Pritzker School of Medicine, Chicago, Illinois 60637, USA
    Catheter Cardiovasc Interv 66:580-4. 2005
    ..We conclude that the 40 mm ASO is safe and effective in most patients with a large ASD up to a diameter of 39 mm. However, the use of this device requires careful attention as the procedure may be unsuccessful or the device may embolize...
  15. ncbi Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk
    Zahid Amin
    Joint Division of Pediatric Cardiology, University of Nebraska Creighton University, Children s Hospital, 8200 Dodge Street, Omaha, NE 68114, USA
    Catheter Cardiovasc Interv 63:496-502. 2004
    ..Oversized ASO may increase the risk of erosion. The defect should not be overstretched during balloon sizing. Patients with small pericardial effusion at 24 hr should have closer follow-up...